Get the Stockscreener App
2.5936
2.13%
-0.0564
Cyclerion Therapeutics Inc stock is traded at $2.5936, with a volume of 21,239.
It is down -2.13% in the last 24 hours and down -16.34% over the past month.
Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize breakthrough treatments for serious and orphan diseases. Its focus is on enabling the full therapeutic potential of next-generation sGC stimulators. Its pipeline products include Olinciguat, Praliciguat, and others.
See More
Previous Close:
$2.65
Open:
$2.65
24h Volume:
21,239
Relative Volume:
0.67
Market Cap:
$8.33M
Revenue:
$556.00K
Net Income/Loss:
$-5.28M
P/E Ratio:
-1.212
EPS:
-2.14
Net Cash Flow:
$-6.23M
1W Performance:
-9.31%
1M Performance:
-16.34%
6M Performance:
-33.84%
1Y Performance:
-22.58%
1-Day Range:
$2.55
$2.75
1-Week Range:
$2.51
$2.95
52-Week Range:
$1.27
$9.4699
Cyclerion Therapeutics Inc Stock (CYCN) Company Profile
Name
Cyclerion Therapeutics Inc
Sector
Industry
Phone
617-621-7722
Address
301 BINNEY STREET, CAMBRIDGE, MA
Compare CYCN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CYCN
Cyclerion Therapeutics Inc
|
2.5936 | 9.44M | 556.00K | -5.28M | -6.23M | -2.14 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
Cyclerion Therapeutics Inc Stock (CYCN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-20-21 | Initiated | Truist | Buy |
| Sep-24-21 | Initiated | Cantor Fitzgerald | Overweight |
| Jun-03-19 | Initiated | Credit Suisse | Neutral |
Cyclerion Therapeutics Inc Stock (CYCN) Latest News
Does Cyclerion Therapeutics Inc. show high probability of reboundSwing Trade Planning with Consistent Setup - Newser
Quantitative breakdown of Cyclerion Therapeutics Inc. recent moveChart Risk Profile for Capital Preservation - Newser
Why is Cyclerion Therapeutics Inc. stock attracting strong analyst attentionFree Stock Review Backed By Experts - jammulinksnews.com
How does Cyclerion Therapeutics Inc. generate profit in a changing economyPost Market Recommendation For 2025 - jammulinksnews.com
What makes Cyclerion Therapeutics Inc. stock price move sharplyFree Stock Target Finder For Fast Growth - jammulinksnews.com
Visual trend scoring systems applied to Cyclerion Therapeutics Inc.Free Breakout Momentum Picks With Protection - Newser
Why Cyclerion Therapeutics Inc. stock attracts strong analyst attentionSwing Trade Planning with Consistent Setup - Newser
Is Cyclerion Therapeutics Inc. stock overvalued or undervaluedBreakout Stocks Picks That Work - jammulinksnews.com
How Cyclerion Therapeutics Inc. stock performs during market volatilitySmart Entry Watchlist with Daily Analysis - Newser
Published on: 2025-07-29 18:32:06 - metal.it
What are analysts’ price targets for Cyclerion Therapeutics Inc. in the next 12 monthsAdvanced Screener Target Finder With High Returns - jammulinksnews.com
How strong is Cyclerion Therapeutics Inc. company’s balance sheetExplosive earnings growth - jammulinksnews.com
What is Cyclerion Therapeutics Inc. company’s growth strategyUnlock exclusive stock market forecasts - jammulinksnews.com
How hedge fund analytics apply to MIRA Pharmaceuticals Inc. stockReal Time Screener for Growth Trades - Newser
What are the latest earnings results for Cyclerion Therapeutics Inc.Turn market volatility into profit opportunities - jammulinksnews.com
What catalysts could drive Cyclerion Therapeutics Inc. stock higher in 2025Stay informed with expert market forecasts - jammulinksnews.com
When is Cyclerion Therapeutics Inc. stock expected to show significant growthTop Growth Tracker With Low Risk - jammulinksnews.com
Does Cyclerion Therapeutics Inc. stock perform well during market downturnsMaster stock selection with insider knowledge - jammulinksnews.com
Should I hold or sell Cyclerion Therapeutics Inc. stock in 2025Strong return on assets - jammulinksnews.com
How many analysts rate Cyclerion Therapeutics Inc. as a “Buy”Rapid wealth multiplication - jammulinksnews.com
What institutional investors are buying Cyclerion Therapeutics Inc. stockAchieve superior returns through strategic trading - jammulinksnews.com
Will Cyclerion Therapeutics Inc. Stock Benefit from AI and Green Energy TrendsFree Trading Group - metal.it
Is Cyclerion Therapeutics Inc. Stock Overbought or Oversold RSI Indicator AnalysisFree Exclusive Access to Stock Gurus - Newser
Best Stock Picks for Beginners in India Personalized Stock SelectionAccelerated earnings growth - PrintWeekIndia
What analysts say about Cyclerion Therapeutics Inc. stockFastest-growing stock picks - PrintWeekIndia
Does DJCO stock pay reliable dividendsFree Risk Assessment Services - jammulinksnews.com
Cyclerion Therapeutics Inc. Stock Analysis and ForecastRobust investment performance - PrintWeekIndia
How Cyclerion Therapeutics Inc. stock reacts to Fed policy changesExceptional stock performance - jammulinksnews.com
What drives Cyclerion Therapeutics Inc. stock priceStrong return on assets - Autocar Professional
Cyclerion Therapeutics Inc Stock (CYCN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):